Diseases, Conditions, Syndromes

Novel method combats malaria drug resistance

Researchers from the University of Notre Dame's Eck Institute for Global Health developed a "gene chip" to contribute to the identification of malaria drug resistance, an effort that will allow for real-time response in modified ...

Diseases, Conditions, Syndromes

Pyramax receives positive opinion from the EMA

Pyramax, a fixed-dose combination of pyronaridine and artesunate, becomes the first antimalarial to be granted a positive scientific opinion from the European Medicines Agency (EMA) under Article 58. This once daily, 3-day ...

Diseases, Conditions, Syndromes

Aggressive drug therapy aids superbug evolution

New research raises troubling concerns about the use of aggressive drug therapies to treat a wide range of diseases such as MRSA, C. difficile, malaria, and even cancer.

page 5 from 6